Aster Capital Management
ABBV icon

Aster Capital Management’s AbbVie ABBV Stock Holding History

Aster Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-685
Closed -$172K – 969
2026
Q2 		$172K Sell
685
-2,644
-79% -$569K 0.04% 434
2026
Q1 		$697K Sell
3,329
-7
-0.2% -$1.55K 0.23% 104
2025
Q4 		$762K Sell
3,336
-5,579
-63% -$1.27M 0.33% 50
2025
Q3 		$2.06M Buy
+8,915
New +$1.82M 1.04% 13
2024
Q4 		– Sell
-7,406
Closed -$1.46M – 1078
2024
Q3 		$1.46M Buy
+7,406
New +$1.38M 0.32% 78

Other funds holding ABBV

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Aster Capital Management's ABBV Position: Q3 2026 in Review

Aster Capital Management sold out of AbbVie (ABBV) in Q3 2026, closing a stake of 685 shares — an estimated $172K sold.

Aster Capital Management first reported a position in ABBV in Q3 2024 and held it in 5 quarters. The position peaked at $2.06M in Q3 2025. 3,450 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Aster Capital Management reported no remaining AbbVie position as of Q3 2026 after selling out during the quarter.
  • Aster Capital Management sold 685 AbbVie shares in Q3 2026, an estimated $172K.
  • Aster Capital Management first reported a position in AbbVie in Q3 2024 and held it in 5 quarters.
  • Aster Capital Management's AbbVie position peaked at $2.06M in Q3 2025.
  • 3,450 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.